PMC:6864571 / 4041-4378 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/6864571","sourcedb":"PMC","sourceid":"6864571","source_url":"https://www.ncbi.nlm.nih.gov/pmc/6864571","text":"Whole-exome sequencing and EP are the most cost-effective genetic tests for epilepsy. Our analyses support for a broad population of patients with unexplained epilepsy, starting with these tests. Although less expensive, CMA has lower yield, and its use as the first-tier test is thus not supported from a cost-effectiveness perspective.","tracks":[{"project":"testtesttest","denotations":[{"id":"T3","span":{"begin":66,"end":71},"obj":"Body_part"},{"id":"T4","span":{"begin":189,"end":194},"obj":"Body_part"}],"attributes":[{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"A4","pred":"uberon_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"subj":"T3","pred":"source","obj":"testtesttest"},{"subj":"T4","pred":"source","obj":"testtesttest"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"testtesttest","color":"#b2ec93","default":true}]}]}}